1961
DOI: 10.1210/endo-69-1-21
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Erythropoiesis by Estrogens

Abstract: Both natural and synthetic estrogens have been found to rapidly depress erythropoiesis in male rats. The doses employed and the time relationships obtained in these experiments suggest that estrogens are part of the regulatory mechanism governing red cell production.T HE administration of estrogens has been known to impair erythropoiesis in different animal species, when studied over rather long periods of time. Large doses of estrogens cause severe anemia in dogs (1,2) and mice (3) but in the monkey the effec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
36
2
2

Year Published

1978
1978
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(44 citation statements)
references
References 10 publications
4
36
2
2
Order By: Relevance
“…Especially, 17␤-estradiol (E 2 ), the plasma level of which gradually increases along with the progress of pregnancy and reaches as much as 30 ng/mL at term, around 100 times that of nonpregnant women, 14 has been well studied, with an inhibitory effect on Epo production reported in animal experiments. [15][16][17][18] However, the anemia observed in pregnancy is not derived from E 2 -induced insufficient Epo production, since actual RBC generation increases; the increase in plasma volume surpasses that in RBC mass (about 150% and 120% of those in a nonpregnant woman, respectively), resulting in "dilutional" or "physiologic" anemia. 19 The expansion of RBC volume is obviously derived from increased Epo production, even though it is somewhat suppressed by the large amount of endogenously secreted E 2 or diluted by the increase of plasma volume.…”
Section: Introductionmentioning
confidence: 99%
“…Especially, 17␤-estradiol (E 2 ), the plasma level of which gradually increases along with the progress of pregnancy and reaches as much as 30 ng/mL at term, around 100 times that of nonpregnant women, 14 has been well studied, with an inhibitory effect on Epo production reported in animal experiments. [15][16][17][18] However, the anemia observed in pregnancy is not derived from E 2 -induced insufficient Epo production, since actual RBC generation increases; the increase in plasma volume surpasses that in RBC mass (about 150% and 120% of those in a nonpregnant woman, respectively), resulting in "dilutional" or "physiologic" anemia. 19 The expansion of RBC volume is obviously derived from increased Epo production, even though it is somewhat suppressed by the large amount of endogenously secreted E 2 or diluted by the increase of plasma volume.…”
Section: Introductionmentioning
confidence: 99%
“…If operative in erythroid cells, this mechanism might account for some of the biological effects of estrogens on erythropoiesis. These include induction of anemia in mammals treated with high doses of estrogens (13,15,34,53), reduction of the number of human bone marrowderived erythroid progenitor cells grown in the presence of estrogens (3), and delay of maturation of chicken bone marrow-derived erythroid progenitor cells (45). In the latter case, the block in differentiation is associated with reduced expression of many erythroid-cell-expressed genes (45).…”
mentioning
confidence: 99%
“…It is the fact that direct stimulatory effect of androgen in men in the bone marrow in association with erythropoietin, and an inhibitory effect of estrogen on the bone marrow in women [13,14]. The fact has been approved in vitro and understood that there was a direct link in vivo that androgens raised the hemoglobin levels in males and females [15][16][17]. It is another fact that the person`s hormones change with aging.…”
Section: Discussionmentioning
confidence: 99%